Portal de Periódicos da CAPES

PREVENTION OF INFECTION DURING NEUTROPENIA

1991; Wiley; Volume: 79; Issue: 4 Linguagem: Inglês

10.1111/j.1365-2141.1991.tb08079.x

1365-2141

Thomas R. Rogers,

Fungal Infections and Studies

British Journal of HaematologyVolume 79, Issue 4 p. 544-549 PREVENTION OF INFECTION DURING NEUTROPENIA T. R. Rogers, Corresponding Author T. R. Rogers Department of Medical Microbiology, Charing Cross and Westminster Medical School, LondonDr T. R. Rogers, Department of Medical Microbiology, Charing Cross and Westminster Medical School, 17 Horseferry Road, London SW1P 2AR.Search for more papers by this author T. R. Rogers, Corresponding Author T. R. Rogers Department of Medical Microbiology, Charing Cross and Westminster Medical School, LondonDr T. R. Rogers, Department of Medical Microbiology, Charing Cross and Westminster Medical School, 17 Horseferry Road, London SW1P 2AR.Search for more papers by this author First published: December 1991 https://doi.org/10.1111/j.1365-2141.1991.tb08079.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Aisner J., Murillo, J., Schimpff, S. C. & Steere, A. C. (1979) Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Annals of Internal Medicine, 90, 4–9. Anaissie, E., Bodey, G. P., Kantarjian, H., Ro, J., Vartivarian, S. E., Hopfer, R., Hoy, J. & Rolsto, K. (1989) New spectrum of fungal infections in patients with cancer. Reviews of Infectious Diseases, 11, 369–378. Anderson, H., Scarffe, J. H., Sutton, R. N. P., Hickmott, E., Brigden, D. & Burke, C. (1984) Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial. British Journal of Cancer, 50, 45–49. Armstrong, D. (1984) Protected environments are discomforting and expensive and do not offer meaningful protection. American Journal of Medicine, 76, 685–689. Baglin, T. P., Gray, J. J., Marcus, R. E. & Wreghitt, T. G. (1989) Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy. Journal of Clinical Pathology, 42, 1255–1258. Barnes, R. A. & Rogers, T. R. F. (1989) Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. Journal of Hospital Infection, 14, 89–94. Bodey, G. P., Buckley, M., Sathe, Y. S. & Freireich, E. J. (1966) Quantitative relationships between circulating leukocytes in patients with acute leukemia. Annals of Internal Medicine, 64, 328–340. Bow, E. J., Rayner, E. & Louie, T. J. (1988) Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced Gram-negative sepsis. American Journal of Medicine, 84, 847–854. Brammer, K. W. (1990) Management of fungal infection in neutropenic patients with fluconazole. Haematologie und Bluttransfusion, 33, 546–550. Buckner, C. D., Clift, R. A., Sanders, J. E., Meyers, J. D., Counts, G. W., Farewell, V. T., Thomas, E. D. & The Seattle Marrow Transplant Team (1978) Protective environment for marrow transplant recipients. Annals of Internal Medicine, 89, 893–901. Clift, R. A., Sanders, J. E., Thomas, E. D., Williams, B. & Buckner, C. D. (1978) Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. New England Journal of Medicine, 298, 1052–1057. Cohen, J., Al Hashimi, S., Apperley, J. F., Moore, R. H., Jones, L. & Aber, V. R. (1987) Antibody titres to a rough-mutant strain of Escherichia coli in patients undergoing allogeneic bone-marrow transplantation. Lancet i, 8–10. Conneally, E., Cafferkey, M. T., Daly, P. A., Keane, C. T. & McCann, S. R. (1990) Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplantation, 5, 403–406. Darbyshire, P. J., Weightman, N. C. & Speller, D. C. E. (1985) Problems associated with indwelling central venous catheters. Archives of Disease in Childhood, 60, 129–134. Dekker, A. W., Rozenberg-Arska, M. & Verhoef, J. (1987) Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine, 106, 7–12. De Pauw, B. E., Donnelly, J. P., De Witte, T., Novakova. I. R. O. & Schattenberg, A. (1990) Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients. Bone Marrow Transplantation, 5, 179–182. Ferretti, G., Ash, R. C., Brown, A. T., Largent, B. M., Kaplan, A. & Lillich, T. T. (1987) Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplant. Journal of the American Dental Association, 114, 461–467. Gluckman, E., Lotsberg, J., Devergie, A., Zhao, X. M., Melo, R., Gomez-Morales, M., Nebout, T., Mazeron, M. C. & Perol, Y. (1983) Prophylaxis of herpes infections after bone marrow transplantation by oral acyclovir. Lancet, ii, 706–708. Guiot, H. F., Peters, W. G., Van den Broek, P. J., van der Meer. J. W., Kramps, J. A., Willemze, R. & Van Furth, R. (1990) Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection, 18, 131–137. Hann, I. M., Corringham, R., Keaney, M., Noone, P., Fox, J., Prentice, H. G., Blacklock, H. A., Shannon, M., Gascoigne, E., Boesen, E. & Hoffbrand, A. V. (1982) Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet, i, 826–829. Herrmann, F., Schulz, G., Wieser, M., Kolbe, K., Nicolay, U., Noack, M., Lindemann, A. & Mertelsmann, R. (1990) Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. American Journal of Medicine, 88, 619–624. Hughes, W. T., Armstrong, D., Bodey, G. P., Feld, R., Mandell, G. L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. C., Young, L. S. & Yow, M. D. (1990) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Journal of Infectious Diseases, 161, 381–396. Hughes, W. T., Kuhn, S., Chaudhary, S., Feldman, S., Verzosa, M., Aur, R. J. A., Pratt, C. & George, S. L. (1977) Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. New England Journal of Medicine, 297, 1419–1426. Johnson, E. J., MacGowan, A. P., Potter, M. N., Stockley, R. J., White, L. O., Slade, R. R. & Reeves, D. S. (1990) Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy. Journal of Antimicrobial Chemotherapy, 25, 837–842. Karp, J., Dick, J., Angelopulos, C., Stryzak, J., Lewis, C. & Bosserman, G. (1990) Role of low dose vancomycin (LDV) used prophylactically to prevent multiport central venous catheter (CVC) infection during deep granulocytopenia. Program and Abstracts of 30th ICAAC, abstract no. 255, Atlanta, Georgia. Kotilainen, P., Nikoskelainen, J. & Huovinen, P. (1990) Emergency of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. Journal of Infectious Diseases, 161, 41–44. Levine, A. S., Siegel, S. T., Schreiber, A. D., Hauser, J., Preisler, H., Goldstein, I. A., Seidler, F., Simon, R., Perry, S., Bennett, J. E. & Henderson, E. S. (1973) Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. New England Journal of Medicine, 288, (10), 477–483. Meunier, F. (1989) New methods for delivery of antifungal agents. Reviews of Infectious Diseases, 11, (Suppl. 7), S1605–S1612. Morstyn, G. (1990) The impact of colony stimulating factors on cancer chemotherapy. British Journal of Haematology, 75, 303–307. Nauseef, W. M. & Maki, D. G. (1981) A study of the value of simple protective isolation in patients with granulocytopenia. New England Journal of Medicine, 304, 448–453. Navari, R. M., Buckner, C. D., Clift, R. A., Storb, R., Sanders, J. E., Stewart, P., Sullivan, K. M., Williams, B., Counts, G. W., Meyers, J. D. & Thomas, E. D. (1984) Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. American Journal of Medicine, 76, 564–572. Nord, C. E. & Edlund, C. (1989) Clinical impact of newer quinolones: influence on normal microflora. Journal of Chemotherapy, 1, (1), 18–23. Petersen, F. B., Bowden, R. A., Thornquist, M., Meyers, J. D., Buckner, C. D., Counts, G. W., Nelson, N., Newton, B. A., Sullivan, K. M., McIver, J. & Thomas, E. D. (1987) The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. Bone Marrow Transplantation, 2, 141–148. Ranson, M. R., Oppenheim, B. A., Jackson, A., Kamthan, A. G. & Scarffe, J. H. (1990) Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. Journal of Hospital Infection, 15, 95–102. Rogers, T. R., Haynes, K. A. & Barnes, R. A. (1990) Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet, 336, 1210–1213. Rogers, T. R., Riches, P. G., Walker, S. A. & Joshi, R. (1986) Changes in immunoglobulin levels and implications for immunoglobulin therapy to prevent infection following bone marrow transplantation. Clinical Use of Intravenous Immunoglobulins (ed. by A. Morrell and U. E. Nydegger), pp. 107–115. Academic Press, London . Rozenberg-Arska, M., Dekker, A. W., Verdonck, L. F. & Verhoef, J. (1989) Prevention of bacteraemia caused by alpha-haemolytic streptococci by roxithromycin. Infection, 17, 240–244. Rozenberg-Arska, M., Dekker, A. W. & Verhoef, J. (1983) Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia: decrease in the emergence of resistant bacteria. Infection, 11, 167–169. Samonis, G., Rolston, K., Karl, C., Milter, P. & Bodey, G. P. (1990) Prophylaxis of oropharyngeal candidiasis with fluconazole. Reviews of Infectious Diseases, 12, (Suppl. 3), S364–S368. Sandford, G. R., Merz, W. G., Wingard, J. R., Charache, P. & Saral, R. (1980) The value of fungal surveillance cultures as predictors of systemic fungal infections. Journal of Infectious Diseases, 142, (4), 503–509. Schimpff, S. C. (1980) Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression. Annals of Internal Medicine, 93, 358–361. Shepp, D. H., Dandliker, P. S., Flournoy, N. & Meyers, J. D. (1987) Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients. Transplantation, 43, (5), 654–658. Sherertz, R. J., Belani, A., Kramer, B. S., Elfenbein, G. J., Weiner, R. S., Sullivan, M. L., Thomas, R. G. & Samsa, G. P. (1987) Impact of air filtration on nosocomial aspergillus infections: unique risk of bone marrow transplant recipients. American Journal of Medicine, 83, 709–718. Storring, R. A., Jameson, B., McElwain, T. J., Wiltshaw, E., Spiers, A. S. D. & Gaya, H. (1977) Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet, i, 837–840. Sullivan, K. M., Kopecky, K. M., Jocom, J., Fisher, L., Buckner, C. D., Meyers, J. D., Counts, G. W., Bowden, R. A., Petersen, F. B., Witherspoon, R. P., Budinger, M. D., Schwartz, R. S., Appelbaum, F. R., Clift, R. A., Hansen, J. A., Sanders, J. E., Thomas, E. D. & Storb, R. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. New England Journal of Medicine, 323, 705–712. Tricot, G., Joosten, E., Boogaerts, M. A., Vande Pitte. J. & Cauwen-bergh, G. (1987) Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Reviews of Infectious Diseases, 9, (Suppl. 1), S94–S99. van der Waaij, D., Berghuis. M. M. & Lekkerkerk, J. E. C. (1972) Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. Journal of Hygiene, 70, 605–610. Warren, R. E., Wimperis, J. Z., Baglin, T. P., Constantine, C. E. & Marcus, R. (1990) Prevention of infection by ciprofloxacin in neutropenia. Journal of Antimicrobial Chemotherapy, 26, (Suppl. F), 109–123. Watson, J. G. & Jameson, B. (1979) Antibiotic prophylaxis for patients in protective isolation. Lancet, i, 1183. Watson, J. G., Powles, R. L., Lawson, D. N., Morgenstern, G. R., Jameson, B., McElwain, T. J., Judson, I., Lumley, H. & Kay, H. E. M. (1982) Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet, i, 6–9. Wingard, J. R., Vaughan, W. P., Braine, H. G., Merz, W. G. & Saral, R. (1987) Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. American Journal of Medicine, 83, 1103–1110. Winston, D. J., Ho, W. G., Bruckner, D. A., Gale, R. P. & Champlin, R. E. (1990) Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. American Journal of Medicine, 88, 36–42. Citing Literature Volume79, Issue4December 1991Pages 544-549 ReferencesRelatedInformation